Akèy › Kansè orofaringe › Illinois › Bloomington
Etid klinik pou Kansè orofaringe nan Bloomington, IL
3 etid pou Kansè orofaringe ap chèche patisipan nan sit nan ak bò kote Bloomington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Ap rekriteFaz 2
- Illinois CancerCare-Bloomington, Bloomington
- Carle BroMenn Medical Center, Normal · 2 mi lwen
- Carle Cancer Institute Normal, Normal · 2 mi lwen
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Ap rekriteFaz 2
- OSF Saint Joseph Medical Center, Bloomington
- Illinois CancerCare-Bloomington, Bloomington
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Ap rekriteFaz 3
- OSF Saint Joseph Medical Center, Bloomington
- Illinois CancerCare-Bloomington, Bloomington
Etid Kansè orofaringe nan lòt vil
- Atlanta, GA8 etid
- Edison, NJ8 etid
- Chicago, IL7 etid
- New York City, NY6 etid
- Queens, NY5 etid
- St. Louis, MO5 etid
- Tampa, FL5 etid
- Kansas City, MO5 etid
- Philadelphia, PA5 etid
- Omaha, NE5 etid
- Los Angeles, CA5 etid
- Pittsburgh, PA5 etid
Lòt etid nan Bloomington
- Kansè Poumon ki pa ti selil11 etid
- Kansè poumon9 etid
- Kansè pwostat7 etid
- Kansè kolorektal7 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Kansè nan tete5 etid
- Kansè pankreyas5 etid
- Melanom5 etid
- Kansè Ipofaringe5 etid
- Kansè larinks5 etid
- Kansè bouch5 etid
- Kansè vejik4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.